bf/NASDAQ:CORT_icon.jpeg

COM:CORCEPT

Corcept Therapeutics

  • Stock

USD

Last Close

55.92

22/11 21:00

Market Cap

3.19B

Beta: -

Volume Today

648.55K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
974.50K
-
1.15M
18.16%
1.44M
25.45%
2.01M
38.84%
5.35M
166.89%
12.31M
129.97%
16.82M
36.68%
19.28M
14.61%
19.55M
1.41%
17.49M
10.55%
12.38M
29.22%
average payables
3.09M
-
2.13M
31.01%
1.61M
24.75%
1.81M
12.58%
5.43M
200.66%
8.42M
54.98%
7.90M
6.19%
9.05M
14.48%
8.73M
3.48%
9.44M
8.14%
14.69M
55.54%
average receivables
992.50K
-
2.38M
139.90%
4.78M
100.65%
8.04M
68.30%
19.03M
136.65%
22.89M
20.31%
18.76M
18.06%
23.06M
22.95%
26.91M
16.69%
36.34M
35.04%
50.09M
37.83%
book value per share
0.21
-
-0.03
115.94%
0.17
615.82%
0.37
116.24%
1.68
349.47%
2.39
42.19%
3.25
35.71%
4.53
39.69%
3.25
28.34%
4.70
44.62%
4.53
3.51%
capex per share
-0.00
-
-0.00
35.44%
-0.00
90.77%
-0.00
1,003.16%
-0.00
110.35%
-0.00
30.00%
-0.01
268.27%
-0.01
12.74%
-0.00
62.20%
-0.00
4.63%
-0.00
67.84%
capex to depreciation
-1.72
-
-1.23
28.10%
-0.11
91.11%
-2.23
1,933.13%
-3.95
77.27%
-1.26
68.06%
-0.50
60.31%
-0.55
10.43%
-0.15
72.37%
-0.14
9.03%
-0.06
57.69%
capex to operating cash flow
0.00
-
0.01
85.46%
-0.01
185.45%
-0.01
94.22%
-0.01
34.81%
-0.00
62.53%
-0.01
210.24%
-0.01
1.92%
-0.00
65.71%
-0.00
22.87%
-0.00
68.12%
capex to revenue
-0.01
-
-0.01
46.56%
-0.00
94.84%
-0.00
605.66%
-0.00
10.32%
-0.00
54.93%
-0.00
199.30%
-0.00
1.45%
-0.00
63.37%
-0.00
19.80%
-0.00
71.96%
cash per share
0.55
-
0.24
56.32%
0.38
57.54%
0.47
23.21%
1.42
205.59%
3.22
126.36%
4.90
51.89%
7.29
48.86%
4.17
42.87%
7.51
80.30%
3.30
56.12%
days of inventory on hand
2.80K
-
499.50
82.14%
451.09
9.69%
413.06
8.43%
860.23
108.25%
1.14K
32.15%
1.15K
1.53%
1.38K
19.86%
1.24K
10.32%
1.15K
6.95%
435.34
62.29%
days payables outstanding
6.08K
-
780.49
87.16%
355.35
54.47%
406.15
14.30%
881.07
116.93%
578.54
34.34%
499.82
13.61%
690.11
38.07%
477.45
30.82%
811.74
70.02%
979.72
20.69%
days sales outstanding
50.33
-
45.83
8.93%
45.16
1.48%
44.26
1.99%
64.64
46.07%
25.55
60.47%
23.73
7.12%
27.02
13.86%
27.55
1.96%
40.92
48.54%
41.71
1.92%
debt to assets
0.56
-
0.98
76.03%
0.53
45.84%
0.21
59.76%
0.01
-
0.01
38.14%
0.00
69.15%
0.00
57.83%
0.00
93.80%
debt to equity
1.67
-
-10.00
699.50%
1.49
114.88%
0.35
76.19%
0.01
-
0.01
39.16%
0.00
68.16%
0.00
62.73%
0.00
93.46%
dividend yield
earnings yield
-0.14
-
-0.10
27.86%
-0.01
88.38%
0.01
184.23%
0.06
521.04%
0.05
22.30%
0.07
39.10%
0.04
48.42%
0.05
39.93%
0.05
4.83%
0.03
37.46%
enterprise value
271.28M
-
288.11M
6.20%
506.81M
75.91%
765.84M
51.11%
1.95B
154.14%
1.33B
31.45%
1.07B
19.67%
2.54B
137.44%
1.95B
23.19%
1.73B
11.32%
3.49B
101.57%
enterprise value over ebitda
-6.55
-
-10.49
60.10%
-154.14
1,370.07%
74.60
148.40%
36.82
50.64%
14.91
59.51%
9.60
35.58%
19.85
106.71%
15.70
20.89%
15.39
2.00%
31.87
107.07%
ev to operating cash flow
-7.32
-
-10.52
43.76%
161.92
1,638.55%
41.64
74.28%
31.94
23.30%
11.54
63.88%
7.87
31.74%
16.75
112.67%
11.64
30.48%
14.41
23.74%
27.50
90.92%
ev to sales
26.19
-
10.85
58.57%
10.08
7.12%
9.42
6.56%
12.23
29.81%
5.31
56.56%
3.50
34.15%
7.19
105.65%
5.34
25.73%
4.31
19.24%
7.24
67.93%
free cash flow per share
-0.37
-
-0.27
26.76%
0.03
110.68%
0.16
465.08%
0.53
223.89%
1.00
87.64%
1.18
18.06%
1.31
10.60%
1.45
10.84%
1.12
22.43%
1.14
1.14%
free cash flow yield
-0.12
-
-0.09
21.63%
0.01
106.43%
0.02
287.61%
0.03
30.20%
0.07
153.65%
0.10
30.35%
0.05
48.84%
0.07
46.45%
0.06
24.38%
0.03
36.76%
graham net net
0.14
-
-0.11
173.04%
0.12
210.74%
0.30
153.00%
1.39
368.70%
3.10
123.38%
4.74
53.12%
7.13
50.34%
4.01
43.82%
7.14
78.22%
2.67
62.58%
graham number
1.48
-
0.48
67.22%
0.48
0.25%
0.79
62.95%
6.56
733.30%
5.93
9.59%
7.76
30.75%
9.68
24.82%
8.43
12.88%
10.02
18.82%
9.84
1.76%
income quality
0.81
-
0.87
8.31%
-0.49
155.99%
2.26
562.55%
0.47
79.11%
1.53
225.02%
1.45
5.77%
1.43
0.81%
1.49
4.09%
1.19
20.49%
1.20
0.88%
intangibles to total assets
0
-
0
0
0
-0.07
Infinity%
0
100%
-0.10
Infinity%
-0.06
33.67%
-0.26
318.51%
0
100%
0
interest coverage
-9.19
-
-7.34
20.16%
-1.16
84.17%
4.99
529.91%
1.08K
21,507.38%
33.68
96.88%
22.01
34.65%
31.67
-
interest debt per share
0.40
-
0.37
5.97%
0.29
23.49%
0.15
47.05%
0.00
99.71%
0.02
5,237.08%
0.09
296.11%
0.04
56.31%
0.01
77.18%
0.05
501.53%
0.00
97.53%
inventory turnover
0.13
-
0.73
460.06%
0.81
10.73%
0.88
9.21%
0.42
51.98%
0.32
24.33%
0.32
1.51%
0.26
16.57%
0.29
11.51%
0.32
7.47%
0.84
165.17%
invested capital
1.67
-
-10.00
699.50%
1.49
114.88%
0.35
76.19%
0.01
-
0.01
39.16%
0.00
68.16%
0.00
62.73%
0.00
93.46%
market cap
320.42M
-
302.93M
5.46%
532.28M
75.71%
802.71M
50.81%
2.05B
155.42%
1.54B
24.84%
1.38B
10.21%
3.02B
118.21%
2.29B
24.15%
2.17B
5.29%
3.63B
67.34%
net current asset value
16.25M
-
-7.79M
147.92%
15.54M
299.55%
38.31M
146.54%
111.03M
189.78%
204.78M
84.44%
311.52M
52.12%
475.85M
52.75%
333.44M
29.93%
417.12M
25.10%
343.82M
17.57%
net debt to ebitda
1.19
-
0.54
54.52%
7.75
1,335.88%
-3.59
146.37%
-1.97
45.20%
-2.31
17.38%
-2.79
20.95%
-3.70
32.41%
-2.69
27.20%
-3.87
43.54%
-1.23
68.06%
net income per share
-0.46
-
-0.31
32.58%
-0.06
80.71%
0.07
222.80%
1.14
1,444.89%
0.65
42.52%
0.82
25.98%
0.92
11.52%
0.97
5.91%
0.95
2.38%
0.95
0.02%
operating cash flow per share
-0.37
-
-0.27
26.97%
0.03
110.80%
0.17
468.00%
0.54
222.69%
1.00
86.83%
1.19
18.71%
1.32
10.62%
1.45
10.25%
1.13
22.38%
1.14
0.90%
payables turnover
0.06
-
0.47
678.66%
1.03
119.64%
0.90
12.51%
0.41
53.90%
0.63
52.29%
0.73
15.75%
0.53
27.57%
0.76
44.54%
0.45
41.18%
0.37
17.15%
receivables turnover
7.25
-
7.96
9.80%
8.08
1.50%
8.25
2.03%
5.65
31.54%
14.29
153.00%
15.38
7.66%
13.51
12.17%
13.25
1.92%
8.92
32.68%
8.75
1.88%
research and ddevelopement to revenue
1.98
-
0.69
64.99%
0.31
55.69%
0.29
4.38%
0.25
13.50%
0.30
18.09%
0.29
3.02%
0.32
11.66%
0.31
4.07%
0.33
4.77%
0.38
17.25%
return on tangible assets
-0.73
-
-0.91
24.24%
-0.12
86.39%
0.12
195.96%
0.55
361.46%
0.24
55.72%
0.21
13.81%
0.17
16.37%
0.21
20.37%
0.17
17.18%
0.17
1.76%
revenue per share
0.10
-
0.26
153.42%
0.47
78.93%
0.74
56.33%
1.40
90.66%
2.18
55.33%
2.68
23.05%
3.07
14.40%
3.16
3.20%
3.76
18.92%
4.32
14.71%
roe
-2.19
-
9.26
523.12%
-0.35
103.74%
0.20
156.79%
0.68
243.71%
0.27
59.57%
0.25
7.17%
0.20
20.17%
0.30
47.80%
0.20
32.50%
0.21
3.65%
roic
-0.49
-
-0.50
3.42%
-0.06
88.31%
0.18
409.07%
0.68
272.61%
0.27
60.78%
0.24
10.69%
0.19
17.88%
0.30
52.50%
0.19
34.46%
0.18
7.33%
sales general and administrative to revenue
shareholders equity per share
0.21
-
-0.03
115.94%
0.17
615.82%
0.37
116.24%
1.68
349.47%
2.39
42.19%
3.25
35.71%
4.53
39.69%
3.25
28.34%
4.70
44.62%
4.53
3.51%
stock based compensation to revenue
0.50
-
0.20
60.95%
0.12
38.96%
0.09
27.42%
0.08
3.30%
0.09
12.62%
0.10
1.19%
0.09
0.90%
0.12
23.77%
0.11
9.97%
0.10
3.94%
tangible asset value
21.02M
-
-3.39M
116.12%
18.50M
645.99%
41.38M
123.69%
206.77M
399.69%
275.88M
33.43%
410.53M
48.81%
559.53M
36.29%
488.08M
12.77%
501.84M
2.82%
506.70M
0.97%
tangible book value per share
0.21
-
-0.03
115.94%
0.17
615.82%
0.37
116.24%
1.68
349.47%
2.39
42.19%
3.25
35.71%
4.53
39.69%
3.25
28.34%
4.70
44.62%
4.53
3.51%
working capital
45.57M
-
16.68M
63.41%
28.10M
68.54%
38.31M
36.33%
111.03M
189.78%
204.78M
84.44%
311.52M
52.12%
513.69M
64.90%
374.48M
27.10%
417.12M
11.39%
354.13M
15.10%

All numbers in USD (except ratios and percentages)